Print   

Thursday 28 January, 2010

Raven Russia Limited

Issue of ordinary shares

RNS Number : 2312G
Raven Russia Limited
28 January 2010
 







 


RAVEN RUSSIA LIMITED 


("Raven Russia" or the "Company")



Issue of ordinary shares



The Company announces that it has approved the issue and allotment of 1,730,782 new ordinary shares of GBP0.01 per share in the Company following an exercise of warrants. These shares will rank pari passu with all existing ordinary shares. Application has been made for admission of the new ordinary shares to trading on the Alternative Investment Market of the London Stock Exchange and dealings are expected to commence tomorrow.

In conformity with the FSA's Disclosure and Transparency Rules, following admission of the new ordinary shares, the Company's capital consists of 514,428,376 ordinary shares with voting rights. 


The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules. 


The total number of warrants now in issue is 140,689,017.

 


 

  Enquiries

 

Raven Russia Limited
Tel: +44 (0)1481 71 2955
Anton Bilton / Glyn Hirsch
 
 
 
Pelham Bell Pottinger
Tel:  +44 (0)20 7861 3881
Charles Cook / Dan de Belder
 
 
 
Numis Securities Limited (NOMAD, Financial Adviser and Joint Broker to Raven Russia Limited)
Tel: +44 (0)20 7260 1000
Nick Westlake / Rupert Krefting
 
 
 
 
 





This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFERLLIDFII

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.